We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
DELISTED
Avanos Medical
AVNS
| $18.4M | 0.02% |
+739,829
| New | +$17.3M |
2026 Q2
0 quarters
|
|
727
Kodiak Gas Services
KGS
$4.86B
| $18.4M | 0.02% |
+244,965
| New | +$16.7M |
2026 Q2
0 quarters
|
|
728
SouthState Bank Corp
SSB
$10.2B
| $18.4M | 0.02% |
184,209
+113,267
| +160% | +$10.9M |
2025 Q2
4 quarters
|
|
729
CALL
American Express
AXP
$213B
| $18.4M | 0.02% |
54,400
+30,700
| +130% | +$9.8M |
2023 Q4
10 quarters
|
|
730
PUT
KLA
KLAC
$207B
| $18.3M | 0.02% |
60,800
+800
| +1% | +$159K |
2023 Q4
10 quarters
|
|
731
iShares MSCI Brazil ETF
EWZ
$11.1B
| $18.3M | 0.02% |
529,503
-417,176
| -44% | -$15.6M |
2023 Q4
10 quarters
|
|
732
PUT
Procter & Gamble
PG
$367B
| $18.2M | 0.02% |
124,300
-7,200
| -5% | -$1.05M |
2021 Q4
18 quarters
|
|
733
CALL
PPL Corp
PPL
$26.4B
| $18.2M | 0.02% |
+500,000
| New | +$18.5M |
2026 Q2
0 quarters
|
|
734
Pharvaris
PHVS
$2.3B
| $18.1M | 0.02% |
524,302
+62,051
| +13% | +$1.88M |
2025 Q3
3 quarters
|
|
735
AMC Entertainment Holdings
AMC
$2.67B
| $18.1M | 0.02% |
9,520,000
+8,232,810
| +640% | +$14.2M |
2025 Q2
4 quarters
|
|
736
CALL
BILL Holdings
BILL
$4.09B
| $18.1M | 0.02% |
500,000
-250,000
| -33% | -$9.21M |
2024 Q3
7 quarters
|
|
737
Ovid Therapeutics
OVID
$478M
| $18.1M | 0.02% |
6,719,076
+1,186,003
| +21% | +$3.06M |
2025 Q3
3 quarters
|
|
738
Walker & Dunlop
WD
$1.17B
| $18M | 0.02% |
329,771
+262,706
| +392% | +$13.3M |
2026 Q1
1 quarter
|
|
739
iShares Core S&P Small-Cap ETF
IJR
$105B
| $17.9M | 0.02% |
121,022
+18,253
| +18% | +$2.5M |
2025 Q2
4 quarters
|
|
740
Everpure Inc
P
$46.2B
| $17.9M | 0.02% |
+227,744
| New | +$16.7M |
2026 Q2
0 quarters
|
|
741
PUT
Carvana
CVNA
$65B
| $17.9M | 0.02% |
272,300
+64,800
| +31% | +$4.58M |
2022 Q4
14 quarters
|
|
742
UiPath
PATH
$7.4B
| $17.8M | 0.02% |
+1,636,736
| New | +$17.5M |
2026 Q2
0 quarters
|
|
743
MoonLake Immunotherapeutics
MLTX
$1.05B
| $17.8M | 0.02% |
912,715
-152,895
| -14% | -$2.77M |
2022 Q3
15 quarters
|
|
744
Plexus
PLXS
$6.38B
| $17.7M | 0.02% |
58,864
+10,945
| +23% | +$2.85M |
2025 Q3
3 quarters
|
|
745
Brunswick
BC
$4.46B
| $17.6M | 0.02% |
+208,458
| New | +$16.7M |
2026 Q2
0 quarters
|
|
746
Papa John's
PZZA
$610M
| $17.5M | 0.02% |
477,286
+415,669
| +675% | +$14.3M |
2025 Q4
2 quarters
|
|
747
Q2 Holdings
QTWO
$4.23B
| $17.5M | 0.02% |
363,452
+125,277
| +53% | +$5.95M |
2025 Q4
2 quarters
|
|
748
CALL
General Mills
GIS
$17.7B
| $17.4M | 0.02% |
+500,000
| New | +$17.3M |
2026 Q2
0 quarters
|
|
749
Bankunited
BKU
$3.05B
| $17.4M | 0.02% |
358,172
-347,460
| -49% | -$16.3M |
2024 Q4
6 quarters
|
|
750
CALL
State Street SPDR S&P Biotech ETF
XBI
$11B
| $17.3M | 0.02% |
109,600
-29,600
| -21% | -$4M |
2023 Q3
11 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.